Slaveyko Dzhambazov headshot

Slaveyko Djambazov, PhD, Dr.

Founder and Managing Director

HTA Ltd.

International healthcare consultancy in health policy advisory, health technology assessment (HTA), investment planning. Graduated medicine, has MBA from AUBG, masters in public health, holds a PhD in HTA, completed executive education in Value measurement for healthcare (VMHC) at Harvard Business School. Teaches HTA, pharmacoeconomics, VMHC, co-author of >10 books on relevant topics and >90 scientific papers. For the last 6 years he’s managing HTA Ltd., with >600 analyses, >130 of them for orphan drugs, rare diseases; 19/20 top Pharma, 3/5 top medical devices companies. Since 2017 Dr. Djambazov has been active with health policy advisory and large health investment projects in Africa, Central and South East Asia.

Advertizing
Advertizing

Other speakers in 2021

Petar Delchev headshot

Bulgaria

Petar Delchev, PhD

Head of Laboratory
Eurofins HOS Testing Bulgaria EOOD (Part of Eurofins Scientific)
Timm Pauli headshot

Germany

Timm Pauli

Head of Global Regulatory Informatics and Operations
PharmaLex
John Krakauer headshot

USA

Dr. John Krakauer, Prof.

Professor of Neurology, Neuroscience, and Physical Medicine & Rehabilitation
Johns Hopkins School of Medicine
Skip to content